Androgen Deprivation Therapy for Prostate Cancer Linked To Increased Alzheimer’s Risk: Study
Researchers warn that the use of androgen deprivation therapy to treat prostate cancer may increase the risk of Alzheimer's disease later in life.
December 11, 2015 By: Irvin Jackson
Researchers warn that the use of androgen deprivation therapy to treat prostate cancer may increase the risk of Alzheimer's disease later in life.
The new federal judge overseeing all talcum powder lawsuits has called for a Science Day to educate the court ahead of planned Daubert hearings which could decide if bellwether test trials can move forward.
Plaintiffs filing Tepezza hearing loss lawsuits claim Horizon Therapeutics, the manufacturer, knew for years that the thyroid eye disease was linked to widespread reports of hearing problems.
The U.S. government has outlined requirements for qualifying for Camp Lejeune elective option settlement offers.